The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Reed Thomas D. since 2013.
The trader's CIK number is 1583188.
At the time of the last reporting, Reed Thomas D. was the Chief Science Officer of Precigen, Inc.. (stock ticker symbol PGEN).
Also see all insider trading activities at Precigen, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | XON | 0 | $0 | 11,935 | $68,582 | 43,046 | $0 |
| 2019 | XON | 0 | $0 | 267,929 | $1,219,043 | 41,417 | $9,411 |
| 2017 | XON | 0 | $0 | 0 | $0 | 38,598 | $101,898 |
| 2014 | XON | 640 | $9,984 | 0 | $0 | 0 | $0 |
| 2013 | XON | 1,800 | $28,800 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-01-04 | XON | Option Ex | 18,940 | .00 | 0 |
| 2020-01-06 | XON | Sale | 5,416 | 5.83 | 31,569 |
| 2020-01-03 | XON | Sale | 2,986 | 5.77 | 17,229 |
| 2020-01-02 | XON | Option Ex | 9,766 | .00 | 0 |
| 2020-01-02 | XON | Sale | 3,533 | 5.60 | 19,784 |
| 2019-12-31 | XON | Option Ex | 14,340 | .00 | 0 |
| 2019-10-01 | XON | Sale | 3,658 | 5.50 | 20,104 |
| 2019-09-30 | XON | Option Ex | 14,341 | .00 | 0 |
| 2019-06-30 | XON | Option Ex | 14,341 | .00 | 0 |
| 2019-07-01 | XON | Sale | 3,527 | 7.76 | 27,369 |
| 2019-03-04 | XON | Sale | 225,500 | 4.21 | 949,355 |
| 2019-03-05 | XON | Sale | 2,300 | 4.66 | 10,718 |
| 2019-02-07 | XON | Option Ex | 2,969 | 3.17 | 9,411 |
| 2019-01-02 | XON | Option Ex | 9,766 | .00 | 0 |
| 2019-01-03 | XON | Sale | 2,944 | 7.07 | 20,817 |
| 2018-12-31 | XON | Sale | 30,000 | 6.36 | 190,680 |
| 2017-10-16 | XON | Option Ex | 38,598 | 2.64 | 101,898 |
| 2014-05-13 | XON | Buy | 640 | 15.60 | 9,984 |
| 2013-08-13 | XON | Buy | 1,800 | 16.00 | 28,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reed Thomas D. (Chief Science Officer of Precigen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.